R&D | January 21, 2026
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
Waskyra is an ex vivo gene therapy that uses patients’ own CD34+ hematopoietic stem and progenitor cells, genetically engineered with a lentiviral vector
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
Subscribe To Our Newsletter & Stay Updated
